Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Kalady

Colon & Rectal Surgery Columbus, OH Medical Doctor

NPI 1639180003 CMS profile 300845

2050 Kenny Rd, Columbus, OH 43221

Open in the dashboard

General payments

$65,549

124 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Kalady of Columbus, OH is reported in the CMS Open Payments database as having received $65,549 across 124 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $31,406 42
2024 General $9,468 12
2023 General $2,014 10
2022 General $4,014 27
2021 General $5,714 7
2020 General $124 3
2019 General $12,809 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Kalady
  • Colon & Rectal Surgery median
  • Middle half of Colon & Rectal Surgery
  • National median

In program year 2025, general payments to Matthew Kalady were reported at $31,406. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.

Show as a table
Year Matthew Kalady Colon & Rectal Surgery median Middle half National median
2019 $12,809 $443 $125–$2,179 $163
2020 $124 $167 $53–$931 $114
2021 $5,714 $207 $72–$1,272 $132
2022 $4,014 $341 $111–$1,587 $149
2023 $2,014 $322 $115–$1,420 $160
2024 $9,468 $328 $112–$1,354 $164
2025 $31,406 $317 $109–$1,248 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $43,119 70 payments
  2. Biom'Up SA $11,934 11 payments
  3. Activ Surgical, Inc. $6,916 11 payments
  4. Medtronic, Inc. $1,307 6 payments
  5. Myriad Genetic Laboratories, Inc. $582 6 payments
  6. Dilon Technologies, Inc. $323 4 payments
  7. Prescient Surgical $296 2 payments
  8. Ethicon US, LLC $267 5 payments
  9. Allergan Inc. $261 3 payments
  10. AbbVie, Inc. $149 1 payment
  11. Other $394 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $19,000 8 payments
  2. Consulting Fee $17,283 7 payments
  3. Education $15,997 10 payments
  4. Travel and Lodging $7,239 30 payments
  5. Food and Beverage $6,030 69 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $40,619 69 payments
  2. Hemoblast $11,934 11 payments
  3. ActivSight Robotic Surgery $5,455 4 payments
  4. DA VINCI SP $2,500 1 payment
  5. ActivSight Surgery $741 3 payments
  6. ActivSight Digital Surgery $720 4 payments
  7. myRisk $403 5 payments
  8. HEMOBLAST BELLOWS $323 4 payments
  9. CleanCision $296 2 payments
  10. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $283 2 payments
  11. Other $1,446 16 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 48 billing codes

Paid by Medicare

$46,005

Medicare's payments for the services billed

Medicare patients

89

Average age 71

Services billed

238

45 women, 44 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Cancer 75%
High blood pressure 62%
Arthritis 38%
Ischemic heart disease 33%
Depression 26%
Diabetes 25%
Atrial fibrillation 25%
Chronic kidney disease 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

124 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Colon & Rectal Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record